{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T05:08:49Z","timestamp":1733548129087,"version":"3.30.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijpt.2024.100635","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T16:51:31Z","timestamp":1730479891000},"page":"100635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proton Versus CyberKnife Therapy Planning for Hypofractionated Treatment of Prostate With Focal Boost"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-0512","authenticated-orcid":false,"given":"Inhwan","family":"Yeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Goughenour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-3935","authenticated-orcid":false,"given":"George","family":"Cernica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Parniani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Kanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2024.100635_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijrobp.2021.01.016","article-title":"Stereotactic body radiotherapy for high-risk localized carcinoma of the prostate (SHARP) consortium: analysis of 344 prospectively treated patients","volume":"110","author":"van Dams","year":"2021","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2003.10.011","article-title":"Proton therapy for prostate cancer: the initial Loma Linda University experience","volume":"59","author":"Slater","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2013.11.007","article-title":"Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer","volume":"88","author":"Mendenhall","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/0284186X.2014.953260","article-title":"A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer","volume":"54","author":"Kole","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib5","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180010","article-title":"Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability","volume":"91","author":"Goddard","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijpt.2024.100635_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2021.02.014","article-title":"Ultrahypofractionated proton radiation therapy in the treatment of low and intermediate-risk prostate cancer-5-year outcomes","volume":"110","author":"Kubes","year":"2021","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13014-019-1210-7","article-title":"Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation","volume":"14","author":"Ha","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13014-015-0522-5","article-title":"Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer","volume":"10","author":"Yeo","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib9","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/0284186X.2021.1947523","article-title":"Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesions","volume":"60","author":"Moteabbeda","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mp.14013","article-title":"Evaluation of newly implemented dose calculation algorithms for multileaf collimator-based CyberKnife tumor-tracking radiotherapy","volume":"47","author":"Kawata","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1748-717X-8-58","article-title":"Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ijrobp.2010.11.054","article-title":"Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer","volume":"82","author":"King","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ijrobp.2007.11.067","article-title":"Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations","volume":"70","author":"Fuller","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib14","first-page":"3","article-title":"Stereotactic ablative body radiosurgery (SABR) or stereotactic body radiation therapy (SBRT)","volume":"109","author":"Folkert","year":"2017","journal-title":"Adv\u00a0Drug Deliv\u00a0Rev"},{"key":"10.1016\/j.ijpt.2024.100635_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2018.06.008","article-title":"Patient reported outcomes in NRG oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer","volume":"102","author":"Lukka","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2018.12.045","article-title":"Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer","volume":"104","author":"Zelefsky","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib17","unstructured":"NRGOncology. RTOG0938. Radiation Therapy in Treating Patients with Prostate Cancer.\u00a0September, 2011. https:\/\/www.nrgoncology.org\/Clinical-Trials\/Protocol\/rtog-0938?filter=rtog-0938."},{"issue":"1","key":"10.1016\/j.ijpt.2024.100635_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2009.10.008","article-title":"Confirmation of a low \u03b1\/\u03b2 ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics","volume":"79","author":"Proust-Lima","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2024.100635_bib19","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9\u20132.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ijpt.2024.100635_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2024.100635_bib21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/cancers15041288","article-title":"The association between acute and late genitourinary and gastrointestinal toxicities: an analysis of the PACE B study","volume":"15","author":"Ratnakumaran","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ijpt.2024.100635_bib22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijpt.2024.100635_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2021.05.013","article-title":"Prostate SBRT dose escalation (9Gy x 5, 13.3Gyx3, 24Gyx1): are we making progress?","volume":"111","author":"Nagar","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2021.03.025","article-title":"A multi-institutional phase II trial of high-dose SAbR for prostate cancer using rectal spacer","volume":"111","author":"Folkert","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2021.03.027","article-title":"Toxicity at 1 year after stereotactic body radiotherapy in 3 fractions for localized prostate cancer","volume":"111","author":"Magli","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2024.100635_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamaoncol.2021.0039","article-title":"Safety and efficacy of virtual prostatectomy with single-dose radiotherapy in patients with intermediate-risk prostate cancer: results from the PROSINT phase 2 randomized clinical trial","volume":"7","author":"Greco","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518024007017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518024007017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:01:33Z","timestamp":1733479293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518024007017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":26,"alternative-id":["S2331518024007017"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2024.100635","relation":{},"ISSN":["2331-5180"],"issn-type":[{"type":"print","value":"2331-5180"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Versus CyberKnife Therapy Planning for Hypofractionated Treatment of Prostate With Focal Boost","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2024.100635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"100635"}}